FDA DEVICE FACTS
X Series®, R Series®, AED Pro®, AED 3™ BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower™
ZOLL Medical Corporation
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
A. X Series Defibrillator Function
The X Series system is indicated for defibrillation on victims of cardiac arrest where there is apparent lack of circulation as indicated by:
• Unconsciousness.
• Absence of breathing.
• Absence of pulse.
The X Series system in the Manual mode is indicated for synchronized cardioversion of certain atrial or ventricular arrhythmias. A qualified physician must decide when synchronized cardioversion is appropriate. The X Series system Semiautomatic and Manual mode is indicated for use in early defibrillation programs where the delivery of a defibrillator shock during resuscitation involving CPR, transportation, and definitive care are incorporated into a medically-approved patient care protocol. The X Series system Semiautomatic and Manual mode is indicated for adult and pediatric patients. Electrocardiogram (ECG) Monitoring The X Series system is indicated to monitor and/or record 3-, 5-, or 12-lead electrocardiogram (ECG) waveform and heart rate, and to alarm when heart rate is above or below limits set by the operator. ECG monitoring is indicated for patients from newborn (neonate) to adult, with and without heart dysfunction. CPR Monitoring The X Series system is indicated to provide visual and audio feedback via the CPR Monitoring function, designed to encourage rescuers to perform chest compressions at the AHA/ERC recommended depth and rate of 2 inches (5 cm) and 100 compressions per minute. The CPR Monitoring function is indicated for adult and pediatric patients. External Transcutaneous Pacing The X Series system is indicated for temporary external cardiac pacing in conscious or unconscious patients as an alternative to endocardial stimulation. External Pacing is indicated for pediatric and adult patients. Non-Invasive Blood Pressure Monitoring The X Series system is indicated for use to make non-invasive measurements of arterial pressure and heart rate, and to alarm if either parameter is outside of the limits set by the user. The non-invasive blood pressure monitoring feature is indicated for patients from newborn (neonate) to adult. Temperature Monitoring The X Series system is indicated for use to make continuous temperature measurements of rectal, esophageal, or surface temperatures, and to alarm if the temperature is outside of the limits set by the user. The temperature monitoring feature is indicated for use in patients from newborn (neonate) to adult.
SpO2 Monitoring The X Series system is indicated for use for continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2), pulse rate, and/or carboxyhemoglobin saturation (SpCO), methemoglobin saturation (SpMet), total hemoglobin (SpHb), oxygen content (SpOC), pleth variability index (PVI), and perfusion index (PI) via the pulse Co-oximeter and accessories. The pulse Co-oximeter and accessories are indicated for use on adult, pediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused, in hospitals, hospital-type facilities, or in mobile environments. Respiration Monitoring The X Series system is indicated for use to continuously monitor respiration rate and to alarm if the rate falls outside of the range set by the operator. Because the measurement method actually measures respiratory effort, apnea episodes with continued respiratory effort (such as obstructive apnea) may not be detected. It is not intended to be used as an apnea monitor. The respiration monitoring feature is indicated for use on patients from newborn (neonate) to adult. CO2 Monitoring The X Series system is indicated for use in continuous noninvasive measurement and monitoring of carbon dioxide concentration of the expired and inspired breath and breath rate. The CO2 monitoring feature is indicated for use on patients from newborn (neonate) to adult. Invasive Pressure Monitoring The X Series system is indicated for use to display and make continuous invasive pressure measurements via a compatible pressure transducer. The invasive pressure monitoring feature is indicated for use on patients from newborn (neonate) to adult. 12-Lead Analysis The X series system is indicated for use in acquiring, analyzing and reporting physiological data via 12-lead ECG Analysis, and to provide interpretation of the data for consideration by caregivers. The 12-lead ECG Analysis feature is indicated for use on adults (> 18 years of age). Web Console The X Series system is indicated for the remote display of physiological data displayed on connected X Series systems via the Web Console feature, including electrocardiogram (ECG), non-invasive blood pressure (NIBP), temperature, and heart rate. B. R Series Defibrillator Function The R Series system is indicated for defibrillation on victims of cardiac arrest where there is apparent lack of circulation as indicated by:
• Unconsciousness.
• Absence of breathing.
• Absence of pulse.
The R Series system in the Manual mode is indicated for synchronized cardioversion of certain atrial or ventricular arrhythmias. A qualified physician must decide when synchronized cardioversion is appropriate. The R Series system Semiautomatic and Manual mode is indicated for use in early defibrillation programs where the delivery of a defibrillator shock during resuscitation involving CPR, transportation, and definitive care are incorporated into a medically-approved patient care protocol. The R Series system Semiautomatic and Manual mode is indicated for adult and pediatric patients. ECG Monitoring The R Series system is indicated to evaluate the patient’s heart rate or ECG morphology via ECG monitoring. In ECG monitoring mode, the feature is indicated for use by personnel who are qualified by training in the use of the R Series defibrillator, basic life and/or advanced life support, or other physician-authorized emergency medical training. Real CPR Help The R Series system is indicated to provide visual and audio feedback via the CPR Help feature, which is designed to encourage rescuers to perform chest compressions at the AHA/ERC recommended depth and rate of 2 inches (5 cm) and 100 compressions per minute. External Pacemaker The R Series system is indicated for temporary external cardiac pacing in conscious or unconscious patients as an alternative to endocardial stimulation. External Pacing is indicated for pediatric and adult patients. SpO2 Monitoring The R Series system is indicated for the continuous, noninvasive monitoring of arterial oxygen saturation (SpO2) and pulse rate during both no motion and patient motion conditions for adult patients, and no motion conditions for pediatric and neonatal patients in a hospital or prehospital environment. EtCO2 Monitoring The R Series system is indicated for the continuous noninvasive monitoring of end tidal carbon dioxide (EtCO2) and respiration rate in patients requiring ventilator support, in-hospital transport, or anesthesia. EtCO2 Monitoring is indicated for in patients from newborn (neonate) to adult. Non-Invasive Blood Pressure Monitoring (NIBP) The R Series system is indicated for the non-invasive measurement of arterial blood pressure for resting patients in critical care and in-hospital transport. The NIBP feature is indicated to measure blood pressure for patients from newborn (neonate) to adult.
C. AED Pro
The AED Pro system is indicated for use on victims of cardiac arrest with apparent lack of circulation as indicated by:
• Unconsciousness
• Absence of breathing, and
• Absence of pulse and other signs of circulation.
The device is also indicated for use when ECG monitoring is indicated to evaluate the patient’s heart rate or ECG morphology. The AED Pro system is indicated for adult and pediatric patients.
D. AED 3 BLS The ZOLL AED 3 system is indicated for use when a suspected cardiac arrest victim has an apparent lack of circulation as indicated by:
• Unconsciousness
• Absence of breathing, and
• Absence of pulse and other signs of circulation.
The AED 3 system is indicated for adult and pediatric patients.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。